CRR_Call Tracker

Text/HTML

Text/HTML

ValueProductView

ValueProductPastPerformance

Company NameReco DateReco PriceExit PriceExit Date% ReturnIn days
Bharat Forge Ltd. 25/07/20241,593.85952.3007/04/2025 -40.25% 256 days
ITC Ltd. 28/12/2023464.20487.5002/01/2025 5.02% 1 yrs
Britannia Industries Ltd. 27/07/20234,875.805,028.2512/11/2024 3.13% 1 yrs
JSW Steel Ltd. 22/02/2024826.951,003.0026/09/2024 21.29% 217 days
Bajaj Auto Ltd. 22/08/20249,910.0011,930.0017/09/2024 20.38% 26 days
Dr. Reddy's Laboratories Ltd. 26/10/20235,429.306,536.0005/07/2024 20.38% 253 days
Shriram Finance Ltd. 25/04/20242,430.102,955.0028/06/2024 21.60% 64 days
Coal India Ltd. 25/01/2024389.50501.6022/05/2024 28.78% 118 days
Infosys Ltd. 27/10/20221,522.601,411.6019/04/2024 -7.29% 1 yrs
State Bank Of India 25/05/2023581.30782.0505/03/2024 34.53% 285 days

CRR_MVC_PastPerformance

Text/HTML

Our Other Trader Products

EasyDNNNews

34 Per Cent Returns From 52-Week Low: Penny Stock Under Rs 5 Jumps Over 9 Per Cent Today
DSIJ Intelligence-1
/ Categories: Trending, Penny Stocks

34 Per Cent Returns From 52-Week Low: Penny Stock Under Rs 5 Jumps Over 9 Per Cent Today

The stock is up by 34 per cent from its 52-week low of Rs 1.94 per share.

On Thursday, one of the Top Gainers on BSE, shares of Evexia Lifecare jumped 9.70 per cent to Rs 2.60 per share from its previous closing of Rs 2.37 per share. The stock is up by 34 per cent from its 52-week low of Rs 1.94 per share.

Evexia Lifecare Limited, formerly known as Kavit Industries Limited, is engaged in the trading of chemicals, agricultural produce and various other products of consumer goods. The company has also formed a new subsidiary firm to set up pathology labs in Africa.

According to the financials, this FMCG company has a market cap of Rs 488 crore and reported positive numbers in its Quarterly Results (Q3FY25) and nine-month results (9MFY25). In its quarterly results, the net sales increased by 221 per cent to Rs 21.70 crore and net profit increased by 340 per cent to Rs 0.12 crore in Q3FY25 compared to Q3FY24 while in its nine-month results, the net sales increased by 122 per cent to Rs 69.64 crore and net profit increased by 170 per cent to Rs 1.05 crore in 9MFY25 compared to 9MFY24.

DSIJ's ‘Penny Pick’ service provides research-backed penny stock recommendations below Rs. 100. If this interests you, do download the service details here.

Earlier, Evexia Lifecare Limited undertook significant strategic moves to bolster its pharmaceutical business. The company has allotted 24 crore convertible warrants to Raghuvir International Pvt Ltd and Shree Saibaba Exim Pvt Ltd, raising capital to fuel future growth. Additionally, Evexia has entered into a Term Sheet with DIPOned Research International Private Limited to acquire a 65 per cent stake, aiming to expand its operations into drug discovery, development, and contract research services, thereby diversifying its portfolio and tapping into a new market

Investors should keep an eye on this micro-cap stock under the radar.

Disclaimer: The article is for informational purposes only and not investment advice. 

Previous Article 17,700% Returns & FIIs Increase Stake: Only Buyers In This Multiubagger EV-Stock Under Rs 65; Locked In Upper Circuit on March 06
Next Article Godfrey Phillips India
Print
316 Rate this article:
3.5
Please login or register to post comments.

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR